
Centenial Surgical Suture: Analytical Perspective Shifts Amidst Mixed Financial and Technical Signals
2025-12-03 08:12:59Centenial Surgical Suture has experienced a revision in its market assessment following a detailed evaluation of its quality, valuation, financial trends, and technical indicators. Despite a challenging financial backdrop and underperformance relative to broader indices, recent technical signals have prompted a nuanced reassessment of the company’s outlook within the healthcare services sector.
Read MoreHow has been the historical performance of Centenial Surgic?
2025-12-02 22:56:51Revenue and Operating Performance Trends Examining Centenial Surgic’s net sales from fiscal 2019 through 2025 reveals a generally stable but somewhat inconsistent revenue pattern. The company recorded net sales of approximately ₹56 crores in 2019 and 2020, followed by a dip to ₹36.93 crores in 2021. This was succeeded by a recovery phase, with sales rising to ₹44.43 crores in 2022 and further to ₹53.52 crores in 2025. Despite this rebound, the sales figures have not consistently surpassed the peak levels seen in 2019 and 2020. Operating profit margins, excluding other income, have fluctuated notably. The margin peaked at 13.54% in 2021 but declined to 11.7% by 2025. This indicates some pressure on operational efficiency, possibly due to rising raw material and other ex...
Read More
Centenial Surgical Suture Faces Revised Market Assessment Amidst Mixed Financial and Technical Signals
2025-11-28 08:07:57Centenial Surgical Suture, a player in the healthcare services sector, has experienced a shift in market evaluation reflecting a complex interplay of financial performance, valuation metrics, and technical indicators. This article analyses the recent changes in the company’s assessment across four key parameters: quality, valuation, financial trend, and technicals, providing investors with a comprehensive understanding of its current market position.
Read More
Centenial Surgical Suture: Analytical Review Highlights Key Evaluation Shifts
2025-11-26 08:11:01Centenial Surgical Suture has experienced notable shifts in its market evaluation, reflecting changes across technical indicators, valuation metrics, financial trends, and overall quality assessments. These developments provide a nuanced perspective on the company’s current standing within the healthcare services sector.
Read More
Centenial Surgical Suture Sees Extraordinary Buying Interest, Hits Upper Circuit
2025-11-25 14:30:20Centenial Surgical Suture Ltd witnessed an exceptional surge in buying activity on 25 Nov 2025, hitting the upper circuit with only buy orders in the queue. This rare market phenomenon highlights intense demand for the stock, with no sellers willing to part with shares at prevailing prices, signalling a potential multi-day circuit scenario.
Read More
Centenial Surgical Suture: Analytical Review Highlights Key Market and Financial Shifts
2025-11-25 08:25:52Centenial Surgical Suture has recently undergone a revision in its market assessment, reflecting notable changes across technical indicators, valuation metrics, financial trends, and overall quality parameters. This article examines the factors influencing the current evaluation of the healthcare services company, providing investors with a comprehensive understanding of its recent performance and outlook.
Read MoreWhy is Centenial Surgic falling/rising?
2025-11-22 00:48:48Recent Price Movement and Market Comparison The stock opened sharply lower, registering a gap down of 4.89% and touched an intraday low of ₹96, trading within a narrow range of just ₹0.35. This limited price movement suggests a lack of strong buying interest to counter the selling pressure. Notably, Centenial Surgical Suture has underperformed its sector by 4.73% on the day, signalling relative weakness compared to its peers. Over the past week and month, the stock has declined by 2.83% and 11.93% respectively, while the benchmark Sensex gained 0.79% and 0.95% in the same periods. Year-to-date, the stock has fallen sharply by 30.43%, contrasting with the Sensex’s positive return of 9.08%. This persistent underperformance highlights ongoing challenges faced by the compa...
Read MoreHow has been the historical performance of Centenial Surgic?
2025-11-18 22:57:57Answer: The historical performance of Centenial Surgic shows a mixed trend over the years, with notable fluctuations in revenue and profitability. Breakdown: Centenial Surgic's net sales have shown an upward trend from Mar'21 to Mar'25, increasing from 36.93 Cr to 53.52 Cr, although there was a dip in Mar'23. Total operating income followed a similar pattern, peaking at 55.61 Cr in Mar'20 before declining and then recovering to 53.52 Cr in Mar'25. The company's total expenditure, excluding depreciation, has generally increased, reaching 47.26 Cr in Mar'25, which has impacted operating profit, which was 6.26 Cr in Mar'25, up from 5.01 Cr in Mar'24. However, profit before tax turned negative in Mar'25 at -1.62 Cr, a significant drop from 1.27 Cr in Mar'24. Consequently, profit after tax also fell to -1.46 Cr in Mar'25, contrasting with the positive figures from previous years. The company's total liabilities...
Read More
Centenial Surgical Suture Q2 FY26: Loss-Making Quarter Extends Concerns as Operational Pressures Mount
2025-11-15 09:19:58Centenial Surgical Suture Ltd., a manufacturer of surgical sutures, reported a loss of ₹0.01 crores for Q2 FY26 ended September 2025, marking its second consecutive loss-making quarter. The ₹38.00 crore market capitalisation company continues to grapple with operational challenges, with net sales declining 5.68% year-on-year to ₹13.46 crores despite a modest 4.02% sequential improvement. The stock has responded sharply to the deteriorating fundamentals, plunging 49.55% from its 52-week high of ₹189.00 to the current price of ₹95.35, with shares trading below all key moving averages in a confirmed bearish trend.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08-Jan-2026 | Source : BSEPFA
Closure of Trading Window
25-Dec-2025 | Source : BSEPFA
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-Nov-2025 | Source : BSEPFA
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available